Ophorst OJ - Search Results

1

Mutational analysis of the putative devazepide binding site of the CCK(A) receptor.

Smeets RL, IJzerman AP, Hermsen HP, Ophorst OJ, Van Emst-de Vries SE, De Pont JJ, Willems PH. Smeets RL, et al. Among authors: ophorst oj. Eur J Pharmacol. 1997 Apr 23;325(1):93-9. doi: 10.1016/s0014-2999(97)00106-4. Eur J Pharmacol. 1997. PMID: 9151944 Free article.

2

Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies.

Donadei A, Kraan H, Ophorst O, Flynn O, O'Mahony C, Soema PC, Moore AC. Donadei A, et al. J Control Release. 2019 Oct;311-312:96-103. doi: 10.1016/j.jconrel.2019.08.039. Epub 2019 Sep 1. J Control Release. 2019. PMID: 31484041

3

Parents' attitude toward multiple vaccinations at a single visit with alternative delivery methods.

Kaaijk P, Kleijne DE, Knol MJ, Harmsen IA, Ophorst OJ, Rots NY. Kaaijk P, et al. Among authors: ophorst oj. Hum Vaccin Immunother. 2014;10(8):2483-9. doi: 10.4161/hv.29361. Hum Vaccin Immunother. 2014. PMID: 25424960 Free PMC article.

4

Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

Ophorst OJ, Radosević K, Klap JM, Sijtsma J, Gillissen G, Mintardjo R, van Ooij MJ, Holterman L, Companjen A, Goudsmit J, Havenga MJ. Ophorst OJ, et al. Vaccine. 2007 Aug 29;25(35):6501-10. doi: 10.1016/j.vaccine.2007.06.019. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17646036

5

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

Ophorst OJ, Radosević K, Ouwehand K, van Beem W, Mintardjo R, Sijtsma J, Kaspers J, Companjen A, Holterman L, Goudsmit J, Havenga MJ. Ophorst OJ, et al. Vaccine. 2007 Feb 9;25(8):1426-36. doi: 10.1016/j.vaccine.2006.10.050. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17161889

6

Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.

de Gruijl TD, Ophorst OJ, Goudsmit J, Verhaagh S, Lougheed SM, Radosevic K, Havenga MJ, Scheper RJ. de Gruijl TD, et al. Among authors: ophorst oj. J Immunol. 2006 Aug 15;177(4):2208-15. doi: 10.4049/jimmunol.177.4.2208. J Immunol. 2006. PMID: 16887980

7

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.

Ophorst OJ, Radosević K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsmit J, Tsuji M. Ophorst OJ, et al. Infect Immun. 2006 Jan;74(1):313-20. doi: 10.1128/IAI.74.1.313-320.2006. Infect Immun. 2006. PMID: 16368986 Free PMC article.

8

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.

Ophorst OJ, Kostense S, Goudsmit J, De Swart RL, Verhaagh S, Zakhartchouk A, Van Meijer M, Sprangers M, Van Amerongen G, Yüksel S, Osterhaus AD, Havenga MJ. Ophorst OJ, et al. Vaccine. 2004 Aug 13;22(23-24):3035-44. doi: 10.1016/j.vaccine.2004.02.011. Vaccine. 2004. PMID: 15297053

9

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A. Havenga MJ, et al. Among authors: ophorst oj. J Virol. 2002 May;76(9):4612-20. doi: 10.1128/jvi.76.9.4612-4620.2002. J Virol. 2002. PMID: 11932426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters